Aakaar Medical Technologies shareholding pattern

AAKAAR

72.7

0.75 (-1.02%)
Last updated on 20 Feb, 2026 | 15:31 IST
alert_iconwatchlist_icon
BUYSELL
Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Aakaar Medical Technologies Shareholding Pattern

  • 2025-26
Total Promoters
Segment
Percent

Total Promoters

67.01%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0.5%

Domestic Institutional Investors

10.73%

Retail

21.77%

Others

-0.01%

Total Promoters
SEP '25
67.01%

Summary

For Year 2025-26, Aakaar Medical Technologies reports the following shareholding: Total Promoters at 67.01%, Mutual Fund at 0%, Insurance at 0%, Foreign Institutional Investors at 0.5%, Domestic Institutional Investors at 10.73%, and Retail at 21.77%. This breakdown provides a quick snapshot of ownership distribution for Aakaar Medical Technologies in 2025-26.

Aakaar Medical Technologies FAQs

As of 02-2026, the promoter shareholding in Aakaar Medical Technologies stands at 67.01% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.

The FII and DII shareholding of Aakaar Medical Technologies is 0.5% and 10.73% respectively.

The retail shareholding of the Aakaar Medical Technologies is 21.77%.

Changes in shareholding patterns of Aakaar Medical Technologies can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.

Shareholding patterns of Aakaar Medical Technologies are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.

The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost